COX-2, Inflammatory Secreted PLA2, and Cytoplasmic PLA2 Protein Expression in Small Bowel Adenocarcinomas Compared with Colorectal Adenocarcinomas

This publication has 25 references indexed in Scilit:

• An insight into the genetic pathway of adenocarcinoma of the small intestine
  Gut, 2002
• Deletion of cytosolic phospholipase A ₂ suppresses Apc ^Min -induced tumorigenesis
  Proceedings of the National Academy of Sciences, 2001
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• REGULATION AND INHIBITION OF PHOSPHOLIPASE A₂
  Annual Review of Pharmacology and Toxicology, 1999
• Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
  Nature Genetics, 1997
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
  Journal of Clinical Investigation, 1997
• High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue
  European Journal Of Cancer, 1996
• Secretory phospholipase A 2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis
  Human Genetics, 1996
• The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
  Cell, 1995
• Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
  Gut, 1994